Sigyn Therapeutics, Inc. Quarterly report pursuant to Section 13 or 15(d)

STOCK TRANSACTIONS (Details Narrative) - USD ($)			1 Months Ended	2 Months Ended
STOCK TRANSACTIONS (Details Narrative) - USD ($)	Jul. 15, 2015	Jun. 30, 2015	Feb. 28, 2015	Mar. 31, 2015	Sep. 30, 2015	Dec. 31, 2014
Deferred offering costs					$ 150,000	$ 75,000
Restricted Stock [Member]
Number of shares issued for services	618,000			300,000
Value of shares issued for services	$ 154,500			$ 75,000
Deferred offering costs					$ 75,000
Restricted Stock [Member] \| General and Administrative Expense [Member]
Number of shares issued for services			40,000
Value of shares issued for services			$ 10,000
Restricted Stock [Member] \| Unrelated third party [Member]
Number of restricted common shares		1,000,000
Value of restricted common shares		$ 250,000
Restricted Stock [Member] \| Brother-in-law CEO [Member]
Number of shares issued for services	10,000
Value of shares issued for services	$ 2,500